An invitation to the WuXi TIDES forum in London

Wenhui Ma — Thu, 16 Mar 2023 07:56:47 +0000

We are pleased to invite you to the WuXi TIDES forum, titled “Accelerating Oligonucleotide Therapeutics from Concepts to Patients“, which will be held on the pre-event day of the 10th annual peptides & oligonucleotides congress.

During this forum, industry thought leaders will discuss some of the challenges that delay development at different stages and the solutions to accelerate oligonucleotide therapeutics from concept to patients. I look forward to meeting you there and at the subsequent reception dinner.

Reserve your free spot

Date: March 29^th, 2023

Forum: 13:34 – 16:45, Novotel London West

Dinner: 19:00 – 22:00, Brasserie Blanc (0.6 miles from Novotel London West)

Speakers:

Dr. Ekkehard Leberer, Senior Life Science Consultant, Elbionic
Timothy Weeden, Vice President, Head of Platform Development, Dyne Therapeutics
Dr. Dave Madge, Vice President, Research Services Division, WuXi AppTec
Dr. Pete Nguyen, Senior Director, WuXi TIDES, WuXi TIDES

Register HERE

Expansion Plan Announced at DCAT Including Oligonucleotide

Wenhui Ma — Mon, 21 Mar 2022 07:52:29 +0000

We thank DCAT for the opportunity to share our capability and capacity expansion plan at the Member Company Announcement Forum during DCAT week last month. We hope our investment across API and drug product for small molecule, oligonucleotide, peptide, and their conjugates will enable more novel medicines to the global market faster.

Read the announcement summary here: https://www.dcatvci.org/supplier-news/wuxi-sta-outlines-major-expansion-plans/

To view more news and webinars, please follow our LinkedIn page.

Wenhui Ma – WuXi TIDES

An invitation to the WuXi TIDES forum in London

Expansion Plan Announced at DCAT Including Oligonucleotide